Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05673031 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
To determine if 68Ga-HA-DOTATATE PET/CT imaging is effective at diagnosing somatostatin positive tumors compared to conventional imaging \[including CT, MRI, 111 In-pentetreotide Scans, 18F-FDG PET/CT, as available\]
Trial Details
NCT Number NCT05673031
Lead Sponsor Alberta Health services
Conditions
(from sponsor)		 Neuroendocrine Tumors (NET)
Related terms Neuroendocrine Tumors
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov